Additionally, treatment with AD was found to inhibit GSK3β activity in mouse brains [22], and genetic variations in GSK3B have been associated with response to selective serotonin reuptake inhibitor AD in Chinese MDD patients [23]. Here, GSK3B is linked to Alzheimer disease.